METHOD FOR INTEGRATED TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
	ALIEV A G D; MAGOMEDOVA M M; ZAKIEVA S I; MIKAILOVA M M
	2023-11-21
专利权人	FEDERAL STATE BUDGETARY EDUCATIONAL (BUDG-Non-standard)
申请日期	2023-11-21
专利号	RU2832137-C1
成果简介	NOVELTY - Invention refers to medicine, namely to ophthalmology and can be used for treating neovascular age-related macular degeneration. That is ensured by the intravitreal introduction of the neoangiogenesis inhibitor brolucizumab in dose of 6 mg. Betamethasone 0.5 ml is introduced into the sub-Tenon space. Preparations are administered three times every 4 weeks; the therapeutic course is 12 weeks. USE - Medicine. ADVANTAGE - Invention provides effective treatment of the given pathology, stable improvement of visual acuity, reduced risk of side effects with reduced frequency of intraocular injections. 1 cl, 1 tbl, 3 ex
IPC 分类号	A61F-009/00 ; A61K-031/573 ; A61K-039/395 ; A61P-027/02
国家	俄罗斯
专业领域	生物科学
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/19218
专题	中国科学院新疆生态与地理研究所
作者单位	FEDERAL STATE BUDGETARY EDUCATIONAL (BUDG-Non-standard)
推荐引用方式 GB/T 7714	ALIEV A G D,MAGOMEDOVA M M,ZAKIEVA S I,et al. METHOD FOR INTEGRATED TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. RU2832137-C1[P]. 2023.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。